This study reports a valuable method to predict the capacity of a candidate probiotic bacterium to metabolically outcompete a bacterial pathogen in the ecological niche of the murine respiratory tract ...

Numerator, the Kantar firm now incorporating Worldpanel, is launching its own consumer-centric measure of inflation, making use of its verified, item-level retail purchase data. The service will be ...

Walmart could see a significant decline in consumer spending if the government suspends Supplemental Nutrition Assistance Program (SNAP) benefits as a result of the ongoing shutdown. According to a ...

In a landmark moment at the ESMO Congress 2025, pivotal studies have unveiled compelling evidence that a new class of anti-cancer agents—antibody-drug conjugates (ADCs)—can dramatically improve ...

It’s been widely reported that U.S. consumers have been angry about the state of the U.S. economy. But why they’re so angry has been more of a puzzle. When we look at economic indicators for retail ...

The U.S. Supreme Court will hear arguments Friday in two cases involving federal law that requires Chinese-owned ByteDance to divest from TikTok, or else TikTok will be banned from U.S. smartphone app ...

Antibody-drug conjugates (ADCs) are innovative treatments targeting specific cancer cell receptors, delivering cytotoxic agents directly to tumors, minimizing systemic exposure. ADCs have shown ...

In 1993, an English literature graduate sat confused in an introductory accounting class at Chicago Booth. To Eric Belcher, ’95, everything the professor said sounded like gibberish, like the words ...

The pneumococcal conjugate vaccines that were studied were the PCV10 (GSK) and PCV13 (Pfizer). The saccharide in PCV10 is conjugated to nontypable Haemophilus influenzae protein D, tetanus toxoid ...

The very first antibody-drug conjugates (ADCs) to enter clinical evaluation sought to improve the therapeutic index of approved anti-cancer drugs, such as doxorubicin and vinblastine, by linking them ...

The hottest cancer technology from the turn of the century is finally getting its glow-up moment, as clinical trials continue to show that antibody-drug conjugates (ADCs) perform better than standard ...